KAB94451
Colorimetric
Plasma, Serum
Quantitative
15.625-1,000 ng/ml
CV<20%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
CAS: 185243-69-0
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation., PMID:40428231
Efficacy, safety, and immunogenicity of biosimilars compared with the biologic etanercept in patients with rheumatoid arthritis: a systematic review and meta-analysis., PMID:39605094
Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: An analysis of current evidence., PMID:38499168
Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis-a study using CoVariant protein arrays., PMID:37937178
Myelin barrier breakdown, mechanical hypersensitivity, and painfulness in polyneuropathy with claudin-12 deficiency., PMID:37527762
Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis., PMID:36253032
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study., PMID:35594016
Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?, PMID:35295608
Hard-to-treat psoriasis in a child developing neutralizing anti-drug antibodies against adalimumab during Streptococcus pyogenes throat infection: a case report., PMID:33348943
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw., PMID:33200254
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium., PMID:33125391
Drug-neutralizing Antibodies against TNF-α blockers as Biomarkers of Therapy Effect Evaluation., PMID:32666748
TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis., PMID:32069329
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents., PMID:31721107
Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it., PMID:31284866
Are new variants of psoriasis therapy (IL-17 inhibitors) safe?, PMID:31192456
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study., PMID:31138316
Contribution of spinal cord glial cells to L. amazonensis experimental infection-induced pain in BALB/c mice., PMID:31138231
Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar., PMID:30533022
A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis., PMID:30451655
Secondary failure of TNF-α inhibitors in clinical practice., PMID:30288872
Targeted therapies for pediatric psoriasis., PMID:30215634
Tropheryma whipplei Increases Expression of Human Leukocyte Antigen-G on Monocytes to Reduce Tumor Necrosis Factor and Promote Bacterial Replication., PMID:30076840
Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway., PMID:28902633
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review., PMID:28612180
Aspirin Blocks Orthodontic Relapse via Inhibition of CD4+ T Lymphocytes., PMID:28060561
Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: Therapeutic implications., PMID:27888159
Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis., PMID:27887675
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis., PMID:27787890
Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha., PMID:27656018
Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis., PMID:27416107
Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis., PMID:26892625
Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required., PMID:26847822
Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors., PMID:26714738
Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?, PMID:26559805
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis., PMID:26558483
Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis., PMID:26366147
Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease., PMID:26170138
Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation., PMID:25760421
Anakinra and etanercept prevent embryo loss in pregnant nonobese diabetic mice., PMID:25602036
Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept., PMID:25494723
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis., PMID:25399390
The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences., PMID:24961616
Potential use of TNF-α inhibitors in systemic sclerosis., PMID:24762073
Etanercept - TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?, PMID:24611432
Antidrug antibodies in psoriasis: a systematic review., PMID:24117166
AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease., PMID:23949620
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy., PMID:23894723
Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases., PMID:23887439
Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study., PMID:23588142
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
